EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Frozen in time: rethinking cryopreservation as a core process parameter in cell and gene therapy

Jason Acker

Cell and Gene Therapy Insights · 09.07.2026 · 12 (5) · 589–596

DOI: 10.18609/cgti.2026.072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell and Gene Therapy Insights, online erschienen am 09.07.2026. Verfasst von Jason Acker. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

“These are complex scientific and technical problems that require and benefit from all the discovery work that we do in the cryopreservation and cryoinjury space.”Wil Rich, Editor, Cell & Gene Therapy Insights , speaks with Jason Acker, Professor, University of Alberta, and Senior Scientist, Canadian Blood Services, about the evolution of biopreservation science, the persistent gap between cryobiology research and cell and gene therapy (CGT) manufacturing practice, and the emerging molecular and chemical strategies that could transform how cell therapies are stabilized, stored, and delivered to patients.

Zitieren

APA

Acker, J. (2026). Frozen in time: rethinking cryopreservation as a core process parameter in cell and gene therapy. Cell and Gene Therapy Insights, 12(5), 589–596. https://doi.org/10.18609/cgti.2026.072

Vancouver

Acker J. Frozen in time: rethinking cryopreservation as a core process parameter in cell and gene therapy. Cell and Gene Therapy Insights. 2026;12(5):589–596. doi:10.18609/cgti.2026.072

BibTeX
@article{Acker2026,
  author = {Acker, Jason},
  title = {Frozen in time: rethinking cryopreservation as a core process parameter in cell and gene therapy},
  journal = {Cell and Gene Therapy Insights},
  year = {2026},
  volume = {12},
  number = {5},
  pages = {589–596},
  doi = {10.18609/cgti.2026.072}
}
Kostenlos starten →